Increases in potassium concentration of dog submaxillary saliva during intravenous infusions of ouabain.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000378:metabolism; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D004562:Electrocardiography; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism*; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D012463:Saliva / Q000187:drug effects* / Q000378:metabolism; D013363:Submandibular Gland / Q000187:drug effects*; D013997:Time Factors
D010042:Ouabain; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D011188:Potassium